Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:


Crossing over to drug resistance

Certain cancers stem from mutations that prevent a cell from repairing its damaged DNA efficiently. But antitumour chemotherapy that exploits that repair defect can in turn be nullified by counter-mutation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout


  1. Edwards, S. L. et al. Nature 451, 1111–1115 (2008).

    Article  CAS  ADS  Google Scholar 

  2. Sakai, W. et al. Nature 451, 1116–1120 (2008).

    Article  CAS  ADS  Google Scholar 

  3. Bryant, H. E. et al. Nature 434, 913–917 (2005).

    Article  CAS  ADS  Google Scholar 

  4. Farmer, H. et al. Nature 434, 917–921 (2005).

    Article  CAS  ADS  Google Scholar 

  5. Nagrath, S. et al. Nature 450, 1235–1239 (2007).

    Article  CAS  ADS  Google Scholar 

  6. Furuta, S. et al. Cancer Cell 10, 13–24 (2006).

    Article  CAS  Google Scholar 

  7. Kinzler, K. W. & Vogelstein, B. Nature 386, 761–763 (1997).

    Article  CAS  ADS  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Livingston, D., Silver, D. Crossing over to drug resistance. Nature 451, 1066–1067 (2008).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing